AUS
NZ
UK
CA
USA
IND
Healthcare
How Is BioVie Boosting Its Capital?
October 21, 2024 02:34 PM PDT| By Team Kalkine MediaHighlights,BioVie Inc. launches a registered direct offering, issuing shares at a set price.,The company is also issuing unregistered warrants in a concurrent private placement.,Proceeds will support working capital and general corporate purposes.,Bi...
PureTech-Founded Seaport Therapeutics Finalizes Oversubscribed Series B Financing Round of $225 Million
October 21, 2024 04:13 AM PDT| By Team Kalkine MediaHighlights,Seaport Therapeutics has successfully closed a $225 million Series B financing round, increasing total capital raised to $325 million since its launch in April 2024.,The financing round was led by General Atlantic, with contributions from...
Walgreens Stock's Trajectory Considered After 20% Surge
October 21, 2024 03:57 AM PDT| By Team Kalkine MediaHighlights,Walgreens reported Q4 FY2024 revenue of $37.5 billion and adjusted earnings of $0.39 per share, surpassing previous estimates and leading to a stock surge of over 20%.,The company anticipates fiscal 2025 sales between $147 billion and $151...
Eli Lilly Earnings Preview: Significant Factors to Monitor
October 21, 2024 03:51 AM PDT| By Team Kalkine MediaHighlights,Eli Lilly and Company (LLY) is set to announce its fiscal third-quarter earnings on October 30, with analysts projecting a significant increase in profit per share compared to the previous year.,The company has consistently surpassed earni...
Strength Highlighted in Corcept (CORT) with 5.5% Increase
October 21, 2024 03:46 AM PDT| By Team Kalkine MediaHighlights,Corcept Therapeutics (CORT) shares increased by 5.5% in the latest trading session, closing at $49.75, driven by robust trading volume.,The company’s marketed drug, Korlym, is experiencing strong demand, while a new drug application for re...
French Government Positioned to Take Stake in Sanofi Unit Post-Private Equity Sale
October 21, 2024 03:33 AM PDT| By Team Kalkine MediaHighlights,France is poised to acquire a 2% stake in Sanofi SA's consumer healthcare unit, Opella, as part of a €16 billion deal with private equity firm Clayton, Dubilier & Rice (CD&R).,The French government expressed concerns regarding foreign cont...
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) Celebrates $225 Million Series B Financing for Seaport Therapeutics
October 21, 2024 02:17 AM PDT| By Team Kalkine MediaHighlights:,Seaport Therapeutics secures $225 million in an oversubscribed Series B round, led by General Atlantic.,Total capital raised by Seaport reaches $325 million since its launch in April 2024.,Funding will advance clinical-stage neuropsychiat...
Oculis Holding AG (Nasdaq: OCS) Accelerates Enrollment in Phase 3 DIAMOND Trials for OCS-01 in Diabetic Macular Edema
October 21, 2024 02:11 AM PDT| By Team Kalkine MediaHighlights:,Enrollment for Phase 3 DIAMOND-1 and DIAMOND-2 trials has surged, with 70% and 40% of patients enrolled, respectively.,The DIAMOND program has expanded its committees with globally recognized retina specialists.,OCS-01 could redefine DME...
Kenvue's Dividend Announcement: Insights and Future Outlook
October 20, 2024 10:49 AM PDT| By Team Kalkine MediaHeadlines,Kenvue Declares Dividend of $0.205 Per Share,Projected Earnings Could Support Future Payouts,Short Payment History Raises Questions,Kenvue Inc.,(NYSE:KVUE),has announced a dividend of $0.205 per share, payable on the 27th of November. This...
Pfizer Inc.Positioned for Success as Economic Trends Shift
October 20, 2024 09:52 AM PDT| By Team Kalkine MediaHeadlines,Pfizer Inc.,(NYSE:PFE),is recognized for its strong return on equity (ROE) among leading stocks.,Shifts in the economic landscape, driven by Federal Reserve rate changes, influence expectations for Pfizer and other stocks.,Morgan Stanley's...
Is CVS Health’s CEO Change a Game-Changer?
October 18, 2024 01:25 PM PDT| By Team Kalkine MediaHighlights,CVS Health Corp announces leadership change, appointing a company veteran as the new CEO.,The company adjusts its profit guidance for the third quarter, citing specific charges impacting earnings.,CVS shares experience a significant declin...
Intuitive Has Released Its Earnings for the Third Quarter
October 18, 2024 03:53 AM PDT| By Team Kalkine MediaHighlights:,Procedure Growth: Worldwide da Vinci procedures increased by 18% year-over-year, indicating a rising adoption of robotic-assisted surgeries.,System Placements: The company placed 379 da Vinci surgical systems in Q3 2024, a significant inc...
Three New U.S. Patents Are Granted to Tenon Medical®
October 18, 2024 03:43 AM PDT| By Team Kalkine MediaHighlights,Tenon Medical® has received the issuance of three new U.S. patents.,These patents enhance the company’s innovative technology portfolio.,The new patents support Tenon Medical’s commitment to advancing healthcare solutions in spinal surgery...
JNJ's Positive Q3 Results Prompt Examination of Stock Opportunities
October 18, 2024 03:34 AM PDT| By Team Kalkine MediaHighlights:,Revenue Growth: Q3 revenue reached $22.5 billion, reflecting a 5.2% year-over-year increase, driven by growth in both the Innovative Medicine and MedTech segments.,Pharmaceutical Performance: The Innovative Medicine segment saw a 4.9% ris...
Insights Into the Future of UnitedHealth Stock Are Offered
October 18, 2024 03:29 AM PDT| By Team Kalkine MediaHighlights:,Revenue Growth: UnitedHealth’s revenue for Q3 reached $100.8 billion, marking a 9% increase year-over-year, driven by sales growth in both the UnitedHealth and Optum segments.,Medical Care Ratio: The medical care ratio stood at 85.2%, hig...
Merck's RSV Jab Is Identified as Having Protective Benefits for Infants
October 18, 2024 02:46 AM PDT| By Team Kalkine MediaHighlights:,Merck & Co Inc's experimental treatment, clesrovimab, has demonstrated positive results in a mid- to late-stage trial for respiratory syncytial virus (RSV).,The treatment showed an over 84% reduction in RSV-related hospitalizations and a...
Can Tonix's Antivirals Boost Military Defense?
October 17, 2024 02:29 PM PDT| By Team Kalkine MediaHighlights,Tonix Pharmaceuticals secures initial payment from the Defense Threat Reduction Agency for antiviral development.,The contract supports research on broad-spectrum antiviral agents targeting military protection.,Tonix utilizes its advanced...
Major themes affecting Intuitive Surgical's Q3 are outlined
October 17, 2024 03:18 AM PDT| By Team Kalkine MediaHighlights,Intuitive Surgical is set to announce its Q3 2024 results on October 17, with projected revenues of $2 billion and adjusted earnings of $1.60 per share.,Continued growth in procedure volume and placements of the da Vinci 5 surgical platfor...
Novavax, Inc. (NASDAQ:NVAX) Shares Tumbled on Wednesday Following Clinical Hold on Flu Combination Vaccine
October 17, 2024 12:24 AM PDT| By Team Kalkine MediaHighlights,Novavax faces a clinical hold following the report of motor neuropathy in a trial participant nearly two years post-vaccination.,Analysts at Jefferies revised their price target for Novavax from $31 to $25 amid increased uncertainty about...
OKYO Pharma Ltd (NASDAQ:OKYO) Begins Patient Recruitment for Phase 2 Trial of OK-101 for Neuropathic Corneal Pain
October 17, 2024 12:18 AM PDT| By Team Kalkine MediaHighlights,The trial aims to address unmet needs in the billion-dollar inflammatory dry eye disease market.,OK-101 is the first targeted treatment for NCP, a condition currently managed only with off-label medications.,The study will evaluate pain re...
